Stoxline.com

Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations

Chicago Rivet & Machine Co. (CVR)

26.24   -0.129 (-0.49%) 11-19 10:47
Open: 0 Pre. Close: 26.3694
High: 26.24 Low: 26.15
Volume: 390 Market Cap: 25M
Chicago Rivet & Machine Co is in the fastener industry in North America. It manufactures rivets, cold-formed fasteners and parts and screw machine products. It operates in two segments of the fastener industry fasteners and assembly equipment.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 26.273 - 26.401 26.401 - 26.527
Low: 25.766 - 25.929 25.929 - 26.091
Close: 25.937 - 26.196 26.196 - 26.452

Technical analysis

as of: 2019-11-19 4:25:24 PM
Overall:       
Stoxline posted a BUY today, same as yesterday. Upward movement continues.
Target: Six months: 30.80     One year: 35.97
Support: Support1: 25.53    Support2: 25.01
Resistance: Resistance1: 26.37    Resistance2: 30.80
Pivot: 25.70
Moving Average: MA(5): 26.01     MA(20): 25.71
MA(100): 26.60     MA(250): 28.20
MACD: MACD(12,26): -0.03     Signal(9): -0.14
Stochastic oscillator: %K(14,3): 73.95     %D(3): 68.48
RSI: RSI(14): 55.57
52-week: High: 33.94  Low: 25.01  Change(%): -17.5
Average Vol(K): 3-Month: 112  10-Days: 20

Price, moving averages and Bollinger Bands

Price and moving averages has closed above its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.
CVR has closed below upper band by 16.2%. Bollinger Bands are 13.5% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Headline News

Mon, 11 Mar 2013 10:28:31 +0000
Benzinga Market Primer, Monday March 11

Wed, 03 Apr 2019 06:18:12 +0000
Is Celgene Stock Still Worth Holding Onto in the Long Run?

Tue, 02 Apr 2019 09:08:00 +0000
Why Celgene's Shares Soared 13.5% in March

Fri, 15 Mar 2019 06:00:00 +0000
Is Celgene and Bristol-Myers a Match Made in Heaven or Doomed to Fail?

Mon, 25 Feb 2019 17:18:00 +0000
Here's Why Clementia Pharmaceuticals Rocketed Higher Today

Financial Analysis

Growth
Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Click here to get more fundamental analysis.
Tweet this page Share on Facebook
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NYSE American
Sector:  Industrials
Industry:  Tools Accessories
Shares Out. (M) 0.97
Shares Float (M) 0.67
% Held by Insiders 18.69
% Held by Institutions 22.05
Shares Short (K)
Shares Short P. Month (K)

Stock Financials

EPS 1.170
Book Value (p.s.) 30.700
PEG Ratio
Profit Margin 3.32
Operating Margin 3.66
Return on Assets (ttm) 2.3
Return on Equity (ttm) 3.8
Qtrly Rev. Growth -7.5
Gross Profit (p.s.) 8.187
Sales Per Share
EBITDA (p.s.) 2.712
Qtrly Earnings Growth 9.70
Operating Cash Flow (M) 2.44
Levered Free Cash Flow (M) -0.03

Stock Valuations

P/E 22.43
P/E Growth Ratio
P/BV 0.85
P/S 0.74
P/CF 10.39

Dividends & Splits

Dividend 0.870
Dividend Yield 0.03
Dividend Pay Date 2019-09-20
Ex-Dividend Date 2019-09-04
Forward Dividend 0.880
Last Split Date
Last Split Ratio -1e+010
7 Binary Options
Your Ad Here
android_stock_chart
Stock Chart
stoxline_lite
Stoxline Lite
stoxline_pro
Stoxline Pro
Option_Calculator
Option Calculator
(c) 2006-2019 Stoxline.com | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.